Filing Details

Accession Number:
0001437749-24-004265
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-15 07:00:19
Reporting Period:
2024-02-13
Accepted Time:
2024-02-15 07:00:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
925741 Biocardia Inc. BCDA;BCDAW Biological Products, (No Disgnostic Substances) (2836) 232753988
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1647542 Peter Altman C/O Biocardia, Inc.
320 Soquel Way
Sunnyvale CA 94085
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-13 108,108 $0.46 555,447 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (right to buy Acquisiton 2024-02-13 54,054 $0.00 54,054 $0.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
121,538 2024-02-13 2026-02-13 No 4 P Direct
Footnotes
  1. On February 13, 2024, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each two shares of common stock purchased.